Cash flows from operating activities: | |
Net income | 45.02M |
Adjustments to reconcile net income to net cash provided by operating activities: | |
Loss (gain) on disposal of assets | |
Depreciation | 60.9M |
Amortization of intangibles | 7.69M |
Deferred income taxes, net of acquisitions | 17.47M |
Loss on redemption of 2026 Convertible Senior Notes, net of make-whole payment | |
Amortization of debt issuance costs | 670K |
Amortization of debt discount | |
Equity-based compensation | 5.3M |
Interest income on restricted assets | |
Closure and post-closure accretion | |
Excess tax benefit associated with equity-based compensation | -4.43M |
Net change in operating assets and liabilities, net of acquisitions | 30.64M |
Net cash provided by operating activities | |
Cash flows from investing activities: | |
Payments for acquisitions, net of cash acquired | -3.56M |
Capital expenditures for property and equipment | -56.58M |
Proceeds from disposal of assets | 681K |
Decrease (increase) in restricted assets, net of interest income | 260K |
Decrease (increase) in other assets | |
Net cash used in investing activities | |
Cash flows from financing activities: | |
Proceeds from long-term debt | 115M |
Principal payments on notes payable and long-term debt | -197.02M |
Change in book overdraft | -151K |
Proceeds from option and warrant exercises | |
Excess tax benefit associated with equity-based compensation | 4.43M |
Payments for repurchase of common stock | 0 |
Payments for cash dividends | -17.79M |
Tax withholdings related to net share settlements of restricted stock units | |
Distributions to noncontrolling interests | |
Debt issuance costs | 0 |
Net cash provided by (used in) financing activities | |
Net increase in cash and equivalents | -1.71M |
Cash and equivalents at beginning of period | 10.97M |
Cash and equivalents at end of period | 9.26M |
Non-cash financing activity: | |
Liabilities assumed and notes payable issued to sellers of businesses acquired | 766K |